SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-18-330412
Filing Date
2018-11-19
Accepted
2018-11-19 17:14:43
Documents
5
Period of Report
2018-11-19

Document Format Files

Seq Description Document Type Size
1 PRE 14A d647608dpre14a.htm PRE 14A 339687
2 GRAPHIC g647608g10k34.jpg GRAPHIC 162456
3 GRAPHIC g647608g19l69.jpg GRAPHIC 258658
4 GRAPHIC g647608g30c53.jpg GRAPHIC 45469
5 GRAPHIC g647608g31k25.jpg GRAPHIC 155448
  Complete submission text file 0001193125-18-330412.txt   1175089
Mailing Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511
Business Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511 312 767 0291
MELINTA THERAPEUTICS, INC. /NEW/ (Filer) CIK: 0001461993 (see all company filings)

IRS No.: 454440364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-35405 | Film No.: 181193362
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences